Literature DB >> 10889451

Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death.

W Y Ong1, X R Lu, C Y Hu, B Halliwell.   

Abstract

Decomposition of lipid peroxides gives rise to a wide range of aldehydes. 4-Hydroxyalkenals and in particular 4-hydroxynonenal (HNE) are often the most toxic products. Frequently, it is unclear at which stage in the tissue injury process HNE is formed, i.e., is it a late stage or an early stage in which HNE contributes to subsequent cell death? The present study was carried out using an antibody to HNE-modified proteins to elucidate the time course and distribution of HNE in the lesioned hippocampus after kainate injections. HNE was absent from normal neurons, but dense staining to HNE was observed in degenerating neurons after kainate injection. The increase in HNE staining occurred as early as 1 d postinjection, at a time when there was no histological evidence of cell death. HNE immunoreactivity was observed in the degenerating CA1 and CA3 fields at 3 d and 1 week postinjection, but was confined to a cluster of neurons at the edge of the degenerating CA fields, at 2 and 3 weeks postinjection. These observations suggest that HNE formation is an early event after this tissue injury, and may contribute to later cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889451     DOI: 10.1016/s0891-5849(00)00238-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Role of oxidative stress in epileptic seizures.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yoon Hee Chung; Won-Ki Kim; Kwang-Ho Ko; Jae-Hyung Bach; Jau-Shyong Hong; Yukio Yoneda; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 3.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

4.  Effect of Resveratrol on Oxidative Stress and Mitochondrial Dysfunction in Immature Brain during Epileptogenesis.

Authors:  Jaroslava Folbergrová; Pavel Ješina; Hana Kubová; Jakub Otáhal
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

Review 5.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.

Authors:  Chandra K Singh; Ambrish Kumar; David B Hitchcock; Daping Fan; Richard Goodwin; Holly A LaVoie; Prakash Nagarkatti; Donald J DiPette; Ugra S Singh
Journal:  Mol Nutr Food Res       Date:  2011-01-20       Impact factor: 5.914

7.  Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders.

Authors:  Ambrish Kumar; Chandra K Singh; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Mol Pharmacol       Date:  2011-06-22       Impact factor: 4.436

Review 8.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  A single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampus.

Authors:  Rubén Darío Castro-Torres; Verónica Chaparro-Huerta; Mario Eduardo Flores-Soto; Jacinto Bañuelos-Pineda; Antoni Camins; Sandra A Orozco-Suárez; Juan Armendáriz-Borunda; Carlos Beas-Zárate
Journal:  J Mol Neurosci       Date:  2013-10-20       Impact factor: 3.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.